US Material Events SEC 8-K Filings — July 28, 2026

Material Events Monitor

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

The July 28, 2026, filing cycle reveals a market with significant capital reallocation and strategic pivots, but also notable leadership disruptions and financial distress. The most critical development is the sudden passing of Carpenter Technology's CEO, creating immediate leadership uncertainty in a key industrial supplier.

Capital markets activity is robust, with several large-scale debt and equity transactions: Galaxy Digital's $3.5B data center financing, Conagra's $500M note offering, and Atlantic Union's $250M subordinated note issuance signal a strong appetite for corporate debt, while Entera Bio's $275M private placement highlights continued biotech funding. The healthcare sector shows a stark contrast, with Centene's operational turnaround (EPS swinging from -$0.51 to +$2.51) juxtaposed against American Shared Hospital Services' acknowledged default and forbearance agreement. A clear theme of 'capital for growth' emerges, with companies like Cadiz ($273.8M in construction contracts) and Core University Living ($303.5M acquisition) deploying significant capital into long-term infrastructure and real estate projects. However, the prevalence of dilutive financing structures (Polar Power's CEF and convertible preferred, T1 Energy's IP acquisition with stock-based payments) and the high number of routine officer changes (12+ filings) suggest a market in transition, where companies are aggressively positioning for the next cycle while managing legacy risks.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from July 27, 2026.

Investment Signals (12)

  • GAAP EPS swung from a loss of $(0.51) in Q2 2025 to a profit of $2.19 in Q2 2026, a massive $2.70/share turnaround. The consolidated HBR improved 340 bps to 89.6%, driven by a 1,080 bps improvement in the Commercial segment (to 79.2%). Full-year adjusted EPS guidance was raised to >$4.80, implying strong H2 confidence.

  • Completed the sale of a Rare Pediatric Disease PRV for $195M in gross proceeds, a non-dilutive capital infusion that significantly strengthens its balance sheet. This provides ample cash runway to fund its pipeline without needing to access equity markets.

  • Subsidiary completed a $3.507B private offering of 9.875% Senior Secured Notes to finance a 400 MW data center project for CoreWeave. The massive scale of this single-project financing (with an uncapped completion guarantee from the parent) signals strong institutional confidence in the AI infrastructure buildout.

  • Raised ~$275M in a private placement to fund the Phase 3 registrational study of EB613 for osteoporosis. The participation of BVF Partners L.P. (a top-tier healthcare fund) and their right to designate two board directors signals strong institutional conviction in the drug's potential.

  • Yarrow Bioscience (fka VYNE Therapeutics) (BULLISH)

    Completed a reverse merger with ~$200M in private financings from top-tier investors (RTW, OrbiMed, Janus Henderson). The combined company has initiated a Phase 2a/2b trial for YB-101 in Graves' disease, with Phase 2a data expected in 2H 2027. The cash runway extends into 2028, de-risking the near-term financing needs.

  • Announced a planned offering of Canadian dollar-denominated senior notes to refinance existing credit facility borrowings. This opportunistic refinancing in a favorable debt market improves financial flexibility and likely extends maturities at attractive rates.

  • Successfully refinanced its credit facilities, increasing revolver capacity to $700M and extending weighted average debt maturity to nearly five years with no significant maturities until 2029. The company has zero outstanding borrowings on its revolver, preserving substantial liquidity for acquisitions.

  • The sudden and unexpected passing of President and CEO Brian Malloy creates immediate leadership vacuum and strategic uncertainty. While Executive Chairman Tony Thene has returned as CEO (a role he held until June 2026), the abrupt transition is a significant disruption.

  • Entered into a Forbearance Agreement with Fifth Third Bank acknowledging existing Events of Default that cannot be cured. The company has $15.4M in total term loans outstanding and is under a standstill period only through June 30, 2027, with a high risk of acceleration or restructuring.

  • Entered into two dilutive financing arrangements (a $25M CEF and a $500K convertible preferred) within the same week. The CEF allows for sales at prevailing market prices, and the convertible preferred includes a 10% discount and warrants, signaling significant potential dilution for existing shareholders.

  • T1 Energy (BEARISH)

    Acquired foundational solar patents for $135M but faces significant financing risk, with $133M payable in four installments through October 2026. The company has a material weakness in internal controls and needs a comprehensive financing solution, with any stock issuance at a 15% discount to VWAP.

  • EVP and General Counsel Eric Nitcher is retiring effective July 31, 2026, with no successor named. The departure of a key legal and strategic executive without a clear replacement creates a temporary governance gap.

Risk Flags (10)

  • President and CEO Brian Malloy passed away suddenly on July 24, 2026. While Executive Chairman Tony Thene has returned as CEO, the unexpected loss of a leader who drove operational excellence creates significant execution risk and potential strategic drift.

  • Acknowledged multiple Events of Default under its credit agreement with Fifth Third Bank. The Forbearance Agreement only provides temporary relief through June 30, 2027, and the company must continue making all payments in cash. With $15.4M in outstanding term loans and no revolver availability, the risk of bankruptcy or distressed restructuring is elevated.

  • Despite a strong earnings turnaround, total at-risk membership declined 7.6% YoY to 25.9 million, with Commercial membership falling 37% and Medicaid down 5.5%. This erosion of the membership base is a structural headwind that could pressure future revenue growth.

  • The $135M IP acquisition requires $133M in cash payments through October 2026, but the company has a material weakness in internal controls and needs a comprehensive financing solution. Any equity issuance to fund payments will be at a 15% discount to VWAP, creating severe dilution risk.

  • The simultaneous entry into a $25M Committed Equity Facility and a $500K Convertible Preferred Stock agreement (with a 10% discount and warrants) creates a dual-pathway to significant shareholder dilution. The CEF allows for sales at market prices, while the preferred can be converted into common stock, both potentially flooding the market with shares.

  • Yarrow Bioscience/Reverse Merger Dilution [MEDIUM RISK]

    The merger with VYNE resulted in a 1-for-50 reverse stock split for legacy VYNE shares, and the combined company has only ~2.8M shares outstanding (33.6M fully diluted). This extreme dilution, combined with the pre-merger $17.3M special dividend, suggests legacy VYNE shareholders were significantly diluted.

  • The formation of Maison AI Limited in Hong Kong is subject to multiple conditions, including Chinese investor cash payments in six monthly installments starting September 2026. The agreement can be terminated if not closed by March 31, 2027, creating significant execution risk for the AI venture.

  • The Third Addendum to the Licensing Agreement with Sagtec Global involves returning 2,000,000 consideration shares and a 50/50 revenue share on MaluDb hosting. The company previously sold 1,660,000 of the original 5,500,000 shares and had an administrative error with excess shares, indicating potential governance and operational control issues.

  • Director William R. McDermott resigned effective immediately on July 27, 2026. While the filing states it was not due to disagreements, the sudden and immediate nature of the resignation without a planned transition is a minor governance concern.

  • CFO Rick Dunn is resigning effective August 21, 2026, with no permanent successor named. The reliance on the SVP and Corporate Controller as interim CFO creates a temporary gap in financial leadership during a critical period.

Opportunities (10)

  • The $195M non-dilutive capital from the PRV sale provides a significant cash infusion without diluting existing shareholders. This strengthens the balance sheet to fund pipeline development and potential strategic acquisitions, with the company trading at a potential discount to its cash-adjusted value.

  • The $275M private placement fully funds the Phase 3 registrational study of EB613 for osteoporosis. With top-tier investor BVF Partners L.P. taking board seats, the trial execution risk is partially mitigated. The upcoming Phase 3 data readout is a major binary catalyst.

  • With a $700M revolver (no outstanding borrowings), a $160M term loan extended to seven years, and improved pricing, the company has maximum financial flexibility. The zero-drawn revolver provides ample dry powder for accretive hotel acquisitions in a potentially distressed market.

  • The $3.5B data center project for CoreWeave positions Galaxy as a major player in the AI infrastructure buildout. The 9.875% yield on the notes reflects the high return potential of this asset class, and the uncapped completion guarantee from the parent signals strong sponsor alignment.

  • The $273.8M in guaranteed maximum price contracts for the Mojave Groundwater Bank Northern Pipeline project represent a major de-risking of the company's core asset. With 21,275 acre-feet per year under existing contracts and potential capacity of 25,000 acre-feet, the project is a significant long-term value driver in a water-scarce region.

  • The $303.5M acquisition of a four-property student housing portfolio (99.4% pre-leased for the 2026-2027 academic year) provides immediate cash flow visibility. The financing structure (SOFR+1.50% with a 4.0% cap) is attractive in the current rate environment, and the 2029 maturity with extension options provides ample time for value creation.

  • The cooperation agreement with Ancora Holdings Group, including the appointment of two new directors and the formation of a Capital Allocation Advisory Committee, signals a potential shift toward shareholder-friendly capital allocation. This could lead to improved operational efficiency, divestitures, or increased buybacks/dividends.

  • The issuance of $250M in 6.25% subordinated notes to repay $168M in 4.25% notes due 2029 is a refinancing that, while increasing the coupon, extends maturities and provides ~$82M in additional capital for general corporate purposes, potentially funding growth or opportunistic acquisitions.

  • The business combination with Westin Acquisition Corp. values FCHS at a pro forma enterprise value of ~$650M, providing a public listing path. The combined company (Wellgevity 360) targets the $2.1T U.S. wellness economy growing at 7.9% annually, offering exposure to a high-growth thematic.

  • CEO Dr. Allan Evans waived all cash compensation after Dec 31, 2026, in exchange for performance-based warrants (5M shares at $25, vesting at stock price targets up to $100). This creates strong alignment with shareholders, as the CEO's compensation is entirely tied to stock price appreciation.

Sector Themes (6)

  • Healthcare Sector Divergence (CROSS-CUTTING)

    The healthcare sector shows a stark contrast between operational turnarounds and financial distress. Centene's massive EPS swing (from -$0.51 to +$2.19) and improved HBR (down 340 bps to 89.6%) contrasts with American Shared Hospital Services' acknowledged default. Meanwhile, biotech continues to attract significant capital (Entera Bio's $275M raise, Yarrow's $200M financing), suggesting a 'barbell' approach where investors favor large-cap managed care and early-stage biotech but avoid mid-cap services.

  • Massive Capital Deployment into AI Infrastructure (CROSS-CUTTING)

    The filings reveal a massive wave of capital flowing into AI-related infrastructure. Galaxy Digital's $3.5B data center financing for CoreWeave is the standout, but Polar Power's focus on data-center power/cooling systems and ConnectM's acquisition of a field services platform for HVAC also point to the broader AI buildout. This theme suggests continued strong demand for energy, cooling, and real estate assets supporting AI.

  • Refinancing Wave in Favorable Debt Markets (CROSS-CUTTING)

    Multiple companies are opportunistically refinancing existing debt to extend maturities and improve terms. Atlantic Union Bankshares ($250M), Apple Hospitality REIT ($860M total facilities), Waste Connections (Canadian dollar notes), and Cboe Global Markets (amended credit facility) all took advantage of market conditions. This suggests a window of favorable credit markets that companies are using to de-risk balance sheets.

  • Executive Leadership Churn (CROSS-CUTTING)

    The filing cycle is characterized by a high volume of officer changes (12+ filings), including retirements, resignations, and new appointments. Notable events include Carpenter Technology's sudden CEO death, Conagra's COO position elimination, and CFO departures at Cross Country Healthcare, TriUnity Business Services, and Satellogic. This level of churn suggests a period of organizational restructuring and strategic repositioning across multiple sectors.

  • Dilutive Financing as a Last Resort (CROSS-CUTTING)

    Several companies are turning to highly dilutive financing structures, signaling limited access to traditional bank debt. Polar Power's dual CEF and convertible preferred (with a 10% discount), T1 Energy's potential stock issuance at a 15% discount, and Kinetic Seas' share-based license fee settlement all point to companies with constrained financing options. This is a red flag for investors in smaller-cap names.

  • Shareholder Activism Driving Board Changes (CROSS-CUTTING)

    The Ashland Inc. cooperation agreement with Ancora Holdings Group is a clear example of activist influence leading to board changes and a new Capital Allocation Advisory Committee. This theme, combined with the broader trend of board refreshment (Adtalem, Haemonetics, NPK International, Diodes), suggests that investors are increasingly demanding governance improvements and strategic accountability.

Watch List (8)

  • The sudden death of CEO Brian Malloy creates immediate uncertainty. Watch for the company's strategy update, any potential departure of other key executives, and the Q3 earnings call for commentary on the leadership transition and operational outlook.

  • The forbearance agreement with Fifth Third Bank runs through June 30, 2027. Watch for any missed payments, covenant breaches, or attempts to restructure the $15.4M in debt. Any negative news could trigger a termination event and accelerate the default.

  • 👁

    With $133M in IP acquisition payments due through October 2026 and a material weakness in internal controls, the company's ability to secure financing is critical. Watch for any equity offering, debt financing, or strategic partnership announcements.

  • The $275M raise fully funds the Phase 3 study of EB613. Watch for trial initiation announcements, enrollment updates, and any early data releases. The participation of BVF on the board suggests a high level of oversight.

  • Yarrow Bioscience (YARW)/Phase 2a Data (MEDIUM PRIORITY)
    👁

    The combined company has initiated a Phase 2a/2b trial for YB-101 in Graves' disease, with Phase 2a data expected in 2H 2027. Watch for trial enrollment updates and any early efficacy signals. The stock's post-merger trading pattern will also be important to monitor.

  • 👁

    Despite the strong earnings beat, the 7.6% YoY decline in at-risk membership is a structural concern. Watch the Q3 2026 filing for any stabilization or further deterioration in membership, particularly in the Commercial (-37% YoY) and Medicaid (-5.5% YoY) segments.

  • The business combination with Westin Acquisition Corp. is expected to close in Q4 2026. Watch for shareholder vote dates, regulatory approvals, and any material changes to the deal terms. The combined company's post-merger trading will be a key indicator of market reception.

  • CFO Rick Dunn departs August 21, 2026, and the company's search for a permanent successor is ongoing. The upcoming earnings call on August 5, 2026, will be a key event to assess the company's financial outlook and the transition plan.

Filing Analyses (50)
Maison Solutions Inc. 8-K mixed materiality 7/10

28-07-2026

Maison Solutions Inc. (MSS) and its wholly owned subsidiary AZLL LLC entered into a Formation, Subscription and Software Contribution Agreement (dated July 22, 2026) to form Maison AI Limited in Hong Kong. AZLL will subscribe for 200 of 222 issued ordinary shares (approximately 90.0901%) in consideration for MSS's Software valued at US$2,000,000, while two Chinese investors (Hangzhou Shengxianbao Technology Co., Ltd. and Yiwu Yanghan E-Commerce Firm) will each subscribe for 11 shares (approximately 4.9550% each) for cash of US$110,000 each (US$220,000 aggregate) payable in six monthly installments beginning on or about September 1, 2026; however, the cash subscribers’ shares will be partly paid until full payment and Closing is subject to conditions and may be terminated if not closed by March 31, 2027.

  • · The cash subscriptions of US$110,000 each are payable in six monthly installments with the first installment due on the later of September 1, 2026 and the fifth Business Day after incorporation and bank account availability.
  • · MSS and its subsidiaries retain a perpetual, worldwide, non-exclusive, irrevocable, royalty-free right to use, host, operate, maintain, modify and integrate the Software for internal business purposes; MSS may not sell or sublicense the Software to unrelated third parties except with the Company’s written consent.
  • · Closing is subject to customary conditions (incorporation, approvals, release of any liens on the Software) and the Shareholders Agreement has not been executed and will only become effective if executed by all shareholders at Closing.
  • · The Formation Agreement may be terminated if Closing has not occurred by March 31, 2027.
  • · Until fully paid, the subscribers’ Shares are partly paid shares and are subject to Articles, this Agreement and the Shareholders Agreement; Articles will include calls, suspension, forfeiture and other provisions under Hong Kong law.
Denali Therapeutics Inc. 8-K positive materiality 8/10

28-07-2026

Denali Therapeutics completed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) to a large pharmaceutical company for gross proceeds of $195.0 million. The PRV was received upon FDA approval of AVLAYAHTM (tividenofusp alfa) for Hunter syndrome in March 2026. The sale closed on July 27, 2026, pursuant to an asset purchase agreement dated June 12, 2026.

  • · PRV was received from FDA approval of AVLAYAHTM for Hunter syndrome (MPS II) in March 2026.
  • · Asset purchase agreement was dated June 12, 2026.
  • · The full text of the PRV Transfer Agreement will be filed as an exhibit to a subsequent SEC filing.
Keen Vision Acquisition Corp. 8-K neutral materiality 3/10

28-07-2026

Keen Vision Acquisition Corp. (KVACU) filed a Fifth Amended and Restated Memorandum and Articles of Association on July 28, 2026, adopted by shareholders on July 21, 2026. The filing updates the company's governing documents, including provisions for share redemption, business combination requirements, and director indemnification. No financial results or material agreements were disclosed in this filing.

  • · The company is authorized to issue up to 500,000,000 shares of USD 0.0001 each.
  • · Public Shares have redemption rights upon Automatic Redemption Event, Tender Redemption Offer, Redemption Offer, or Amendment Redemption Event.
  • · Fair Value for a business combination is defined as at least 80% of the Trust Account balance (excluding deferred underwriting fees and taxes).
  • · The memorandum includes detailed indemnification provisions for directors and officers.
  • · No amendment to the business combination provisions (Regulation 23) is allowed before a business combination unless public shareholders are given redemption rights.
CENTENE CORP 8-K mixed materiality 9/10

28-07-2026

Centene Corporation reported Q2 2026 GAAP diluted EPS of $2.19 and adjusted diluted EPS of $2.51, a significant turnaround from a GAAP loss of $(0.51) per share in Q2 2025. Total revenues rose 4% to $53.6 billion, driven by premium yield and PDP membership growth, while the consolidated HBR improved to 89.6% from 93.0%. However, total at-risk membership declined 7.6% year-over-year to 25.9 million, with Commercial membership falling 37% and Medicaid down 5.5%, partially offset by PDP growth. The company raised its full-year 2026 adjusted diluted EPS guidance to greater than $4.80.

  • · Commercial HBR improved to 79.2% in Q2 2026, demonstrating significant year-over-year improvement in profitability.
  • · Medicare segment HBR of 89.5% included fundamental outperformance in both Medicare Advantage and PDP.
  • · Medicaid HBR of 93.9% was in-line with expectations.
  • · Guidance increase includes approximately $0.50 of non-recurring items in Medicare and Commercial segments.
  • · The company repurchased $260 million of senior notes due 2027 and 2028 during Q2 2026.
  • · No borrowings on the $4.0 billion Revolving Credit Facility at quarter end.
  • · Days in claims payable (DCP) was 47 days, down one day from Q1 2026 due to timing of state directed payments.
  • · Full year 2026 GAAP diluted EPS guidance raised to greater than $3.11; adjusted diluted EPS guidance raised to greater than $4.80.
  • · Full year 2026 total revenues guidance raised by $6.0 billion to a range of $193.5B to $197.5B.
  • · Full year 2026 premium and service revenues guidance raised by $2.0 billion to a range of $173.0B to $177.0B.
  • · Full year 2026 HBR guidance range is 90.5% to 91.3%.
  • · Full year 2026 adjusted SG&A expense ratio guidance range is 6.9% to 7.5%.
  • · Full year 2026 adjusted effective tax rate guidance range is 25.5% to 26.5%.
  • · Full year 2026 diluted shares outstanding guidance range is 497 million to 500 million.
  • · Adjusted net earnings for Q2 2026 were $1,248 million, compared to an adjusted net loss of $(79) million in Q2 2025.
  • · GAAP net earnings for Q2 2026 were $1,091 million, compared to a GAAP net loss of $(253) million in Q2 2025.
  • · Enterprise optimization costs for Q2 2026 were $37 million pre-tax.
  • · Severance costs due to enterprise optimization and contract exits for Q2 2026 were $15 million pre-tax.
  • · Net gain on debt extinguishment for Q2 2026 was $6 million pre-tax.
  • · Amortization of acquired intangible assets for Q2 2026 was $161 million pre-tax.
  • · The company operated MMPs through December 31, 2025; in 2026 these members are included in Medicare due to CMS transition to D-SNP based integration.
Polar Power, Inc. 8-K mixed materiality 7/10

28-07-2026

Polar Power, Inc. (POLA) announced a Committed Equity Facility (CEF) with Roth Principal Investments, LLC for up to $25 million, providing additional working capital flexibility to support growth in its DC power systems business, including data-center power/cooling and drone-charging systems. The facility is discretionary and subject to conditions, including SEC registration, and may be dilutive to existing stockholders. The company is not obligated to use the full amount, and there is no guarantee it can sell all shares due to Nasdaq rules and registration limits.

  • · The CEF is with Roth Principal Investments, LLC, an affiliate of CR Financial Holdings, Inc. (holding company for Roth Capital Partners).
  • · Sales under the facility will be at prevailing market prices and may be dilutive to existing stockholders.
  • · The company intends to file a registration statement with the SEC to register the resale of shares; no sales can occur until that registration is effective.
  • · The facility is discretionary — Polar Power is under no obligation to utilize any or all of the $25 million.
  • · Limitations include the number of shares registered for resale and applicable Nasdaq rules.
Clearfield, Inc. 8-K neutral materiality 2/10

28-07-2026

Clearfield, Inc. entered into Amendment No. 4 to its Loan Agreement with Old National Bank on July 24, 2026, extending the maturity of its line of credit from July 24, 2026 to November 21, 2026. All other material terms remain unchanged. This is a routine extension of credit facility maturity.

  • · Amendment No. 4 extends maturity from July 24, 2026 to November 21, 2026.
  • · Original Loan Agreement dated April 27, 2022.
ConnectM Technology Solutions, Inc. 8-K positive materiality 7/10

28-07-2026

ConnectM Technology Solutions, Inc. (CNTM) acquired Blue Ribbon Ice, a software platform that matches commercial HVAC, refrigeration, and facility-service demand with a nationwide network of independent contractors. The acquisition extends ConnectM's AI-Powered Logistics platform beyond last-mile delivery into commercial field services, adding a network of over 200 independent contractors across 42 states and a new data stream for its shared AI engine. The transaction is described as an EBITDA-accretive tuck-in acquisition, but no financial terms were disclosed.

  • · Blue Ribbon Ice was founded in 2022.
  • · The platform provides emergency repair, preventative maintenance, and installation services.
  • · Every service dispatched is documented with photographs, equipment reporting, and asset tracking.
  • · The acquisition broadens the customer base for ConnectM's logistics platform, creating cross-sell potential between last-mile delivery and commercial field services.
  • · The transaction is part of ConnectM's broader growth strategy of pairing organic growth with selective, EBITDA-accretive tuck-in acquisitions as it advances its planned national exchange uplisting.
Atlantic Union Bankshares Corp 8-K neutral materiality 7/10

28-07-2026

Atlantic Union Bankshares Corporation entered into an underwriting agreement on July 27, 2026, to issue $250 million aggregate principal amount of 6.25% Fixed-to-Floating Rate Subordinated Notes due 2036. The net proceeds will be used to repay $168.0 million of its outstanding 4.25% Fixed-to-Floating Rate Subordinated Notes due 2029, plus accrued interest, and for general corporate purposes. The offering is expected to close on July 30, 2026.

  • · The offering is made under the Company's automatic shelf registration statement on Form S-3ASR (File No. 333-281290), effective August 6, 2024.
  • · The redemption of the 2029 Notes is contingent on the completion of the new offering and the amount of proceeds.
  • · The underwriting agreement includes customary representations, warranties, covenants, indemnification, and contribution obligations.
Polar Power, Inc. 8-K mixed materiality 7/10

28-07-2026

Polar Power, Inc. entered into a Securities Purchase Agreement with LU2 Holdings LLC on July 21, 2026, for the issuance of up to $500,000 in Series A Convertible Preferred Stock at a 10% discount (90% of stated value) and common stock purchase warrants. The transaction is exempt from registration under Section 4(a)(2) of the Securities Act. The agreement includes a beneficial ownership limitation of 9.99% and an exchange cap of 19.99% of outstanding common stock. This financing provides capital but also introduces potential dilution for existing shareholders.

  • · The agreement includes a beneficial ownership limitation of 9.99% of outstanding Common Stock.
  • · The exchange cap limits total shares issued to 19.99% of outstanding Common Stock as of the agreement date.
  • · Existing debt includes loans from Pinnacle Bank, WWCM, notes payable to CEO, and convertible notes to CFI Capital LLC, Monroe Street Capital Partners, LP, and Mayers Ventures LLC.
  • · The offering is exempt from registration under Section 4(a)(2) of the Securities Act.
CROSS COUNTRY HEALTHCARE INC 8-K neutral materiality 9/10

28-07-2026

Knox Lane completed its acquisition of Cross Country Healthcare, taking the company private. Joel Tremblay was appointed CEO, succeeding Kevin C. Clark who retired. The locums division was sold to All Star Healthcare Solutions, a Knox Lane portfolio company.

  • · Transaction closed July 21, 2026.
  • · Cross Country Healthcare becomes a privately held, standalone company.
  • · Kevin C. Clark will support transition.
  • · Joel Tremblay previously President of Medical Solutions.
  • · BofA Securities provided fairness opinion.
  • · Davis Polk & Wardwell LLP legal counsel to Cross Country.
  • · MTS Health Partners financial advisor to Knox Lane; Kirkland & Ellis LLP legal counsel to Knox Lane.
T1 Energy Inc. 8-K positive materiality 8/10

28-07-2026

T1 Energy Inc. (TE-WT) announced the acquisition of foundational solar patents and other IP from Evervolt Green Energy Holding Pte Ltd. for $135 million. The deal eliminates future royalty payments and strengthens T1's position as a vertically integrated U.S. solar manufacturer. However, T1 faces significant financing risks, with $133 million payable in four installments through October 2026, and the company has a material weakness in internal controls and needs a comprehensive financing solution for its capital expenditure.

  • · The patents were previously licensed by T1 from Evervolt.
  • · The acquisition eliminates future royalty payments on the IP.
  • · Any issuance of T1 common stock for installments will be at a 15% discount to a five-trading-day VWAP.
  • · The company has a material weakness in its internal control over financial reporting and requires comprehensive financing for G2_Austin Phase 1.
  • · T1 completed a transformative transaction in December 2024 to position itself as a leading U.S. solar manufacturer.
HORMEL FOODS CORP /DE/ 8-K neutral materiality 6/10

28-07-2026

Hormel Foods announced the appointment of John F. Ghingo, currently President, as President and CEO effective October 26, 2026, succeeding Interim CEO Jeffrey M. Ettinger. Ghingo's annual base salary will increase from $730,000 to $1.28 million, with a short-term incentive target of 150% of salary and a long-term incentive target of $6.8 million. Ettinger will remain on the Board.

  • · Ghingo previously served as CEO of Whisps Acquisition Corporation from January 2022 to August 2024.
  • · Ghingo holds an undergraduate degree in marketing from the University of Notre Dame and an MBA from NYU Stern.
  • · Ettinger's interim CEO service ends October 25, 2026, per a June 20, 2025 Employment Agreement.
  • · Ghingo will be eligible for benefits under the Executive Severance Plan with a severance factor of 2x.
  • · Long-term incentive grants are anticipated to start in December 2026.
CONAGRA BRANDS INC. 8-K neutral materiality 4/10

28-07-2026

Conagra Brands announced that EVP and COO Thomas McGough will retire by September 4, 2026, and the company will eliminate the COO position upon his departure. This represents a structural change in the executive leadership team but does not include any financial metrics or performance data.

  • · The COO position will be eliminated after Mr. McGough's retirement.
  • · Mr. McGough's retirement date is no later than September 4, 2026.
  • · The filing was signed by Carey Bartell, EVP, General Counsel and Corporate Secretary.
Waste Connections, Inc. 8-K neutral materiality 5/10

28-07-2026

Waste Connections announced a planned offering of two series of Canadian dollar-denominated senior notes due 2033 and 2036. The net proceeds, together with cash on hand, will be used to repay a portion of Canadian dollar-denominated borrowings under its revolving credit facility. The offering is subject to market and other conditions.

  • · The notes will be senior unsecured obligations.
  • · The offering will be made in the U.S. under an effective shelf registration statement filed on October 24, 2024, and on a private placement basis in Canada.
  • · Joint book-running managers and underwriters: CIBC Capital Markets, Scotiabank, and TD Securities.
  • · The company serves approximately nine million customers across 46 U.S. states and six Canadian provinces.
  • · Waste Connections also provides non-hazardous oilfield waste treatment and intermodal services.
Kinetic Seas Inc. 8-K mixed materiality 5/10

28-07-2026

Kinetic Seas Inc. entered into a Third Addendum to its Licensing Agreement with Sagtec Global Limited on July 7, 2026, completing the return of 2,000,000 consideration shares to Sagtec and reducing its stake to less than 10% of Sagtec's outstanding shares. The addendum also shortens the Rule 144 holding period on retained shares to six months (already elapsed), eliminates Sagtec's right of first refusal, and grants Sagtec non-exclusive rights to sell MaluDb hosting services internationally. While the agreement resolves certain restrictions and opens new commercial arrangements, it also reflects that Kinetic Seas previously sold 1,660,000 of the original 5,500,000 consideration shares and had an administrative error involving approximately 65,000 excess shares transferred.

  • · The Third Addendum eliminates Sagtec's right of first refusal, allowing Kinetic Seas to freely transfer retained shares.
  • · Kinetic Seas is no longer an affiliate of Sagtec (holds <10% of outstanding shares, not an officer/director).
  • · Sagtec is granted non-exclusive rights to sell MaluDb hosting internationally under the 'Skilliks' brand, with a 50/50 revenue share arrangement.
  • · The six-month Rule 144 holding period on retained shares has already elapsed as of the addendum date.
  • · Sagtec ratified approximately 65,000 excess shares previously transferred by Kinetic Seas due to an administrative error.
CONAGRA BRANDS INC. 8-K neutral materiality 6/10

28-07-2026

Conagra Brands completed a public offering of $500 million aggregate principal amount of 5.400% Senior Notes due 2031. The notes are senior unsecured obligations and rank equally with the company's other senior unsecured debt. Proceeds will be used for general corporate purposes, and the offering was underwritten by BofA Securities, Goldman Sachs, Mizuho, and Wells Fargo.

  • · The notes were issued under a base indenture dated August 12, 2021, as supplemented by a Fourth Supplemental Indenture dated July 28, 2026.
  • · The indenture contains customary covenants limiting the company's ability to incur secured debt, engage in sale and leaseback transactions, and merge or transfer substantially all assets.
  • · The notes mature on August 1, 2031, with interest payments beginning February 1, 2027.
  • · The notes are effectively junior to all existing and future secured and unsecured debt of the company's subsidiaries.
  • · The underwriting agreement was dated July 21, 2026, and includes customary representations, warranties, and indemnification provisions.
Core University Living Real Estate Income Trust 8-K positive materiality 8/10

28-07-2026

Core University Living Real Estate Income Trust completed the acquisition of a four-property student housing portfolio (the 'Seed Portfolio') for $303,500,000 on July 22, 2026. The portfolio, located in Lexington, KY; Morgantown, WV; and Gainesville, FL, was 99.4% pre-leased for the 2026-2027 academic year as of March 31, 2026. The acquisition was funded with a $180,400,400 mortgage loan from JPMorgan Chase and proceeds from share sales, and the loan carries a Term SOFR + 1.50% interest rate with a 4.0% cap.

  • · The seller was a joint venture between a third party and an entity owned by several principals of Core Spaces, LLC, the Company's sponsor.
  • · The loan matures on July 22, 2029, with two one-year extension options subject to conditions including no default, a debt service coverage ratio test, and a loan-to-value ratio not exceeding 60.0% for the first extension.
  • · Partial prepayments must be at least $250,000.
  • · The interest rate cap agreement was entered into by Core Morgantown LLC, a borrower under the Loan.
Ford Credit Auto Lease Trust 2026-B 8-K neutral materiality 3/10

28-07-2026

Ford Credit Auto Lease Trust 2026-B filed an 8-K on July 28, 2026, reporting the entry into material definitive agreements (Transaction Documents) in connection with the issuance of asset-backed securities (Notes) as described in the Prospectus dated July 21, 2026. The filing lists multiple agreements dated July 1, 2026, including an Indenture, Trust Agreement, Servicing Supplement, and various purchase and control agreements, but does not disclose the size of the issuance or any financial terms.

  • · The Prospectus was filed with the SEC under Rule 424(b)(2) on July 21, 2026.
  • · The Transaction Documents are dated as of July 1, 2026.
  • · The filing includes an Asset Representations Review Agreement with Clayton Fixed Income Services LLC as Asset Representations Reviewer.
  • · The Trust is a Delaware statutory trust; the Depositor is Ford Credit Auto Lease Two LLC (Delaware, IRS ID 13-4347114).
  • · No financial statements or exhibits other than the agreements were provided (Items 9.01(a)-(c) marked not applicable).
Zoom Communications, Inc. 8-K neutral materiality 3/10

28-07-2026

On July 27, 2026, director William R. McDermott resigned from the board of Zoom Communications, Inc., effective immediately. The resignation was not due to any disagreement with the company regarding its operations, policies, or practices. No financial metrics or performance data were disclosed in this filing.

  • · William R. McDermott's resignation was effective immediately on July 27, 2026.
  • · The resignation was not due to any disagreements with the company on operations, policies, or practices.
Adeia Inc. 8-K neutral materiality 3/10

28-07-2026

Adeia Inc. announced amendments to severance agreements for its CFO, CRO, and Chief Legal Officer, approved on July 22, 2026. The changes enhance equity acceleration provisions for qualifying terminations, including performance-based awards, but do not alter base severance terms. This is a routine compensation governance update with no immediate financial impact.

  • · Amended agreements cover Qualifying Termination and CIC Qualifying Termination scenarios.
  • · For Qualifying Termination, executives get accelerated vesting of equity awards scheduled to vest within 12 months post-termination.
  • · For CIC Qualifying Termination, all outstanding equity awards accelerate immediately upon later of termination or change in control.
  • · Performance-based awards vest based on actual achievement for completed fiscal years and the greater of target or actual for other goals.
  • · The form of amended agreement will be filed with the Q2 2026 10-Q.
CNH Industrial N.V. 8-K neutral materiality 3/10

28-07-2026

CNH Industrial N.V. announced the retirements of Chief Technology Officer Jay Schroeder (effective January 1, 2027) and Agriculture Chief Commercial Officer Stefano Pampalone (effective September 1, 2026), both after decades of service. Eric Shuman will succeed Schroeder as CTO, while Chun Woytera, Carlo Materazzo, and Markus Müller will assume expanded global leadership roles upon Pampalone's retirement. No financial metrics or performance data were disclosed in this filing.

  • · Effective dates: Schroeder retires January 1, 2027; Pampalone retires September 1, 2026.
  • · Eric Shuman has been with the company for over 25 years, most recently as VP, Precision Technology Product Management since June 2025.
  • · No family relationships or reportable transactions involving Shuman per Regulation S-K Item 404(a).
  • · Compensatory arrangements for Shuman’s new role are not yet finalized.
  • · Both retiring executives will remain in advisory capacities for transition support.
  • · Three executives assume expanded roles upon Pampalone’s retirement: Woytera (Chief Product & Sustainability Officer), Materazzo (Chief Manufacturing & Quality Officer), Müller (President, EMEA and Parts & Service).
TriUnity Business Services Ltd 8-K neutral materiality 3/10

28-07-2026

On July 24, 2026, Independence Power Holdings, Inc. (the Company) announced that CFO Brian Dutton will step down effective August 14, 2026 to pursue another professional opportunity. The Company stated his resignation is unrelated to financial or operating results or any disagreements with Company policies, and it has initiated an external search for a replacement.

  • · CFO resignation effective August 14, 2026
  • · Resignation is for another professional opportunity and not related to financial or operating results or disagreements
  • · External search for replacement CFO has been initiated
KENNAMETAL INC 8-K neutral materiality 3/10

28-07-2026

Kennametal Inc. announced a board leadership transition, with Joseph Alvarado appointed as incoming Chairman effective October 28, 2026, succeeding William Lambert who will retire on October 27, 2026. The change follows Lambert's tenure since 2016 and as Chairman since 2023, during which he guided the company through transformation. No financial or operational results were disclosed, and the filing contains no period-over-period comparisons or negative metrics.

  • · Lambert joined the Board in 2016 and served as Chairman since 2023.
  • · Alvarado has served on the Board since 2018 and was chair of the Nominating/Corporate Governance Committee since 2023.
  • · Alvarado is the retired Chairman, President and CEO of Commercial Metals Company and holds an MBA from Cornell University and a BA in Economics from the University of Notre Dame.
  • · The company has approximately 8,100 employees and generated $2 billion in revenues in fiscal 2025.
Adtalem Global Education Inc. 8-K neutral materiality 3/10

28-07-2026

Adtalem Global Education Inc. (NYSE: ATGE), operating as Covista, announced the appointments of Emily C. Chiu and Leslie Storms to its Board of Directors, effective August 17, 2026. The new directors bring expertise in technology, fintech, edtech, healthcare delivery, medtech, and veterinary medicine, supporting the company's three-year growth strategy, 'Purpose at Scale.' The filing is a routine board composition update and does not include any financial results or negative performance metrics.

  • · Covista is the parent company of five accredited institutions: American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
  • · With the appointments, 10 of Covista's 12 directors will be independent.
  • · Emily Chiu previously co-founded ventures in higher education recognized by EDUCAUSE and The Bill & Melinda Gates Foundation as a 'breakthrough model in college completion'.
  • · Leslie Storms spent nearly two decades at Johnson & Johnson, holding senior leadership roles including President, U.S. Orthopedics and President, U.S. Surgery.
EchoStar CORP 8-K neutral materiality 8/10

28-07-2026

EchoStar Corporation has established a $2.4B Wireless Creditor Trust as a condition of FCC approval for its spectrum license assignments to AT&T and SpaceX. The trust will hold $2.4B in proceeds from the AT&T transaction to pay eligible tort, breach of contract, and other claims related to EchoStar's network construction and operations. A $200M reserve is segregated for Type A claims, with The Bank of New York Mellon serving as trustee.

  • · Trust is named 'Wireless Creditor Trust' and established under FCC Orders DA 26-470 and DA 26-471 dated May 12, 2026.
  • · Trust is intended to be exempt from Securities Act of 1933 and Investment Company Act of 1940.
  • · Trust will remain subject to the FCC Wireless Telecommunications Bureau's continuing jurisdiction.
  • · The $200M Type A Claims Reserve is secured by a security agreement and deposit account control agreement in favor of DISH Wireless L.L.C. as secured party.
  • · Claimants may file only one Covered Claim per person/entity.
  • · Beneficiaries include: (a) holders of Eligible Type A Claims, (b) holders of Eligible Type B-1/B-2 Claims (after Type A and expenses are paid), and (c) EchoStar for any remainder.
CARPENTER TECHNOLOGY CORP 8-K negative materiality 9/10

28-07-2026

Carpenter Technology Corporation announced the sudden and unexpected passing of President and CEO Brian Malloy on July 24, 2026. Executive Chairman Tony Thene has been appointed by the Board to return as CEO effective immediately, a role he previously held from 2015 through June 2026. The company extended condolences to Malloy's family and highlighted his decade of contributions to operational excellence and long-term success.

  • · Brian Malloy passed away suddenly and unexpectedly on Friday, July 24, 2026.
  • · Tony Thene previously served as CEO from 2015 through June 2026.
  • · Thene will also continue in his role as Chairman of the Board.
  • · Carpenter Technology was founded in 1889 and focuses on aerospace, defense, medical, transportation, energy, and industrial markets.
Unusual Machines, Inc. 8-K neutral materiality 6/10

28-07-2026

Unusual Machines, Inc. granted CEO Dr. Allan Evans warrants to purchase 5,000,000 shares at $25.00, vesting upon stock price targets from $25 to $100, in exchange for waiving all cash compensation after Dec 31, 2026. The company also granted stock options to three other executives: President Andrew Camden (525,000 options), CFO Brian Hoff (375,000), and CRO Stacy Wright (375,000), all at $19.36 per share, vesting quarterly over three years. The warrants are subject to shareholder approval.

  • · Warrant exercise price is $25.00 per share, expiring July 24, 2031.
  • · Warrants vest in five equal tranches of 1,000,000 shares each upon stock price targets of $25, $40, $60, $80, and $100.
  • · Stock options for executives are exercisable at $19.36 per share and vest in 12 equal quarterly installments over three years.
  • · CEO Dr. Evans agreed to waive all cash compensation after December 31, 2026 in consideration for the warrant grant.
  • · The warrant grant is subject to shareholder approval.
Apple Hospitality REIT, Inc. 8-K positive materiality 7/10

28-07-2026

Apple Hospitality REIT completed refinancing transactions that increased its revolving credit facility to $700M and upsized a term loan from $130M to $160M with a seven-year maturity extension. The company improved pricing terms across its credit facilities and extended its weighted average debt maturity to nearly five years, with no significant maturities until 2029. As a result, the company has no outstanding borrowings under its revolver, preserving substantial liquidity for growth.

  • · The Main Credit Facility includes an accordion feature allowing increase from $1.3B to $1.75B.
  • · The Seven-Year Term Loan includes an accordion feature allowing increase from $160M to $300M.
  • · Pricing on two other unsecured credit facilities totaling $470M was conformed to match improved pricing of the Main Credit Facility without changing principal amounts or maturities.
  • · The company has no significant debt maturities until 2029.
  • · Weighted average maturity of total consolidated debt extended to nearly five years.
  • · No outstanding borrowings under the revolving credit facility post-closing.
  • · The incremental $30M from the Seven-Year Term Loan was used to reduce revolving credit facility balance and secured debt maturities.
AMERICAN SHARED HOSPITAL SERVICES 8-K negative materiality 8/10

28-07-2026

American Shared Hospital Services (AMS) entered into a Third Amendment to Credit Agreement and Forbearance Agreement with Fifth Third Bank on July 22, 2026, acknowledging that certain Events of Default have occurred and are continuing. The amendment provides a temporary forbearance period through June 30, 2027, during which the lender will not exercise remedies solely for the designated defaults, while the company must continue making all principal and interest payments in cash. The company's outstanding debt includes $4.7M in Term Loans, $2.4M in Delayed Draw Term Loans, $1.9M in Supplemental Term Loans, and $6.4M in Second Supplemental Term Loans, with no Revolving Loans outstanding.

  • · The Designated Events of Default are acknowledged as currently existing and cannot be cured.
  • · The Standstill Period ends on the earlier of June 30, 2027, or the occurrence of a Termination Event (new default, misrepresentation, noncompliance, or Material Adverse Effect).
  • · The Borrowers released the Lender and its affiliates from all claims through the date of the amendment.
  • · The amendment requires payment in full of all Revolving Loan Advances and Unused Line Fees as a condition precedent.
  • · The company must deliver a cash flow forecast showing projected cash receipts and disbursements as a condition.
Oklo Inc. 8-K neutral materiality 3/10

28-07-2026

Oklo Inc. announced the appointment of five executive officers effective July 27, 2026, including Alexandra Renner as Chief Product Officer, John Hanson as Chief of Staff, Vivek Narayanadas as General Counsel and Corporate Secretary, Erik Lassen as Senior Vice President of Engineering, and Michael Dixon as Vice President of Accounting and Controller (Principal Accounting Officer). All appointees are internal promotions or recent hires, with no new compensatory plans, equity awards, or material amendments to existing arrangements. The filing contains no financial data or period-over-period comparisons.

  • · All five appointees have no family relationships with any director or other executive officer of the Company.
  • · No transactions requiring disclosure under Item 404(a) of Regulation S-K exist for any appointee.
  • · The Company did not enter into any new compensatory plan, contract, or arrangement with the appointees, nor grant any equity awards.
Entera Bio Ltd. 8-K positive materiality 9/10

28-07-2026

Entera Bio Ltd. raised approximately $275.0 million in a private placement on July 26, 2026, issuing 122,961,215 ordinary shares and 11,842,695 pre-funded warrants at $2.04 per share to institutional and accredited investors, including funds affiliated with BVF Partners L.P. The proceeds will fund the Phase 3 registrational study of EB613 for osteoporosis and for general working capital. As part of the agreement, BVF gains the right to designate two board directors, and two current independent directors (Haya Taitel and Yonatan Malca) will resign or not stand for reelection as part of an orderly succession plan.

  • · The private placement closed on July 28, 2026.
  • · Pre-funded warrants have an exercise price of NIS 0.0000769 per share, are immediately exercisable, have no expiration, and are subject to customary adjustments.
  • · BVF's board designation right reduces to one director if beneficial ownership falls below 75% of the securities acquired, and terminates if below 50% of those securities or below 10% of total outstanding ordinary shares.
  • · The company agreed to use commercially reasonable efforts to appoint two additional independent directors (New Independent Directors) by the 2027 annual general meeting, and no later than 18 months after closing.
  • · Purchasers agreed to vote in favor of proposals to increase shares under the 2018 Equity Incentive Plan and to restore executive officers' ownership percentages post-placement.
  • · A registration statement for resale of the shares and warrant shares must be filed within 30 days of closing.
  • · Haya Taitel and Yonatan Malca will resign or not stand for reelection upon appointment of corresponding New Independent Directors, with no disagreement with the company.
Bark, Inc. 8-K positive materiality 5/10

28-07-2026

BARK, Inc. announced the appointment of Anya Hamill as Chief Financial Officer, effective September 8, 2026. Ms. Hamill brings over 20 years of financial leadership experience from public CPG companies and private equity-backed firms, most recently serving as CFO of Laird Superfood from 2022 to 2026. The outgoing interim CFO, Brian Dostie, will remain as Vice President, Accounting and Controller. This is a positive leadership addition, but no financial metrics or performance data were disclosed in this filing.

  • · Ms. Hamill's appointment is effective September 8, 2026.
  • · She previously served as CFO of Laird Superfood from 2022 to 2026.
  • · She also served as CFO of Little Secrets Chocolates from 2018 to 2022.
  • · Brian Dostie, who served as Interim CFO for the past year, will continue as VP, Accounting and Controller.
CADIZ INC 8-K positive materiality 8/10

28-07-2026

Cadiz Inc., through its affiliate Fenner Gap Mutual Water Company, entered into two Construction Manager at Risk (CMAR) agreements on July 27, 2026, for the Mojave Groundwater Bank Northern Pipeline project. The Lyles Agreement sets a guaranteed maximum price (GMP) of approximately $218.9 million for pump stations, and the Bubalo Agreement sets a GMP of approximately $54.9 million for pipeline replacement, totaling $273.8 million. The total estimated construction capital expenditure is $403.3 million, with the remaining $129.5 million for owner-procured equipment and contingencies; the project is expected to deliver 21,275 acre-feet per year under existing contracts, with a potential total capacity of 25,000 acre-feet per year.

  • · The GMP agreements include 50/50 sharing of unused contingency between Fenner Gap and the contractor.
  • · Construction is expected to commence after issuance of notices to proceed, anticipated this calendar year (2026).
  • · The agreements assume a September 2026 notice to proceed but do not automatically terminate if notice is later.
  • · The Bubalo Agreement includes 10% project contingency; the Lyles Agreement includes 15%.
  • · Fenner Gap has secured contractual pricing for replacement pipe and power generation equipment through existing purchase options.
HAEMONETICS CORP 8-K positive materiality 5/10

28-07-2026

Haemonetics Corporation announced the election of Dr. Martin Madaus to its Board of Directors, effective July 24, 2026. Dr. Madaus brings over 30 years of leadership experience in diagnostics and life sciences, having served as CEO of Ortho Clinical Diagnostics and Millipore Corporation, and currently as Senior Operating Executive at The Carlyle Group. The appointment strengthens the board with deep operational, commercial, and strategic expertise, though no specific financial metrics or performance changes were disclosed.

  • · Dr. Madaus currently serves as Senior Operating Executive at The Carlyle Group, advising on healthcare investments since 2019.
  • · He previously led Ortho Clinical Diagnostics' turnaround after its carve-out from Johnson & Johnson.
  • · He holds a Doctor of Veterinary Medicine from the University of Munich and a Ph.D. in Veterinary Medicine from the Veterinary School of Hanover in Germany.
  • · Dr. Madaus serves as Chair of the Board of Repligen Corporation and as a board member of Azenta, Inc.
NPK International Inc. 8-K positive materiality 3/10

28-07-2026

NPK International Inc. appointed Kristen J. Pederson to its board of directors effective July 28, 2026. Ms. Pederson brings extensive public company board, strategic planning, governance, finance, and audit experience, and will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees. The appointment strengthens the board's expertise as the company executes its strategy and expands market presence.

  • · Ms. Pederson holds an MBA from Harvard Business School and completed undergraduate studies at the University of California, Los Angeles.
  • · She previously held senior roles at IBM and was a partner at Ernst & Young LLP and PricewaterhouseCoopers LLP.
  • · She currently serves as a director of SOBR Safe, Inc. and Eagle Bancorp, Inc.
Terrestrial Energy Inc. /DE/ 8-K neutral materiality 4/10

28-07-2026

Terrestrial Energy Inc. announced the appointment of Kathryn McCarthy to its Board of Directors, bringing decades of nuclear science and technology leadership from national laboratories. The company also set its Q2 2026 earnings release and conference call for August 11, 2026. No financial results or performance metrics were disclosed in this filing.

  • · Kathryn McCarthy holds a Ph.D. in nuclear engineering from UCLA and is a member of the National Academy of Engineering and a Fellow of the American Nuclear Society.
  • · McCarthy previously served as Senior Advisor at Oak Ridge National Laboratory since 2026, supporting strategic decisions in the US ITER Project and fusion research.
  • · The Q2 2026 earnings call will be held on August 11, 2026, at 8:30 a.m. Eastern Time, with CEO Simon Irish and CFO Brian Thrasher participating.
  • · Terrestrial Energy is targeting the early 2030s for building, licensing, and commissioning the first IMSR Plants.
Satellogic Inc. 8-K neutral materiality 5/10

28-07-2026

Satellogic Inc. announced that CFO Rick Dunn will resign effective August 21, 2026, as previously disclosed. The company's search for a permanent successor is ongoing, and if no successor is appointed by the separation date, SVP and Corporate Controller Dustin Greer is expected to serve as interim CFO. The transition will be discussed on the upcoming earnings call scheduled for August 5, 2026.

  • · Rick Dunn's resignation as CFO is effective August 21, 2026.
  • · Dustin Greer, age 47, has served as Corporate Controller since 2022 and previously was Senior Director, FP&A and Business Insights at Trilogy International Partners.
  • · No material plan, contract, or arrangement has been entered into with Mr. Greer in connection with the expected interim CFO appointment.
  • · The company will discuss the transition during its earnings call on August 5, 2026.
DIODES INC /DEL/ 8-K positive materiality 3/10

28-07-2026

Diodes Incorporated elected Evan Yu to its Board of Directors as an independent director, effective August 1, 2026. Yu is a former Senior Vice President of Worldwide Power Products at Diodes, having retired in January 2023, and brings deep semiconductor expertise and international experience. The appointment strengthens the board's governance and strategic oversight, with Yu qualifying as independent under Nasdaq and SEC rules.

  • · Yu previously served as Senior Vice President, Worldwide Power Products at Diodes from 2008 until his retirement in January 2023.
  • · Before Diodes, Yu was CEO of Commit Inc., an Asian wireless communications chipset company focused on 3G/4G technologies.
  • · Yu worked at Texas Instruments for 15 years, including as Asia Vice President of the Application Specific Products (ASP) organization.
  • · Yu most recently served as Chairman of the Board of Canyon Semiconductor Inc.
  • · Yu studied electrical engineering at Kaohsiung Institute of Technology and earned his bachelor's degree in Electrical Engineering at Tam Kang University in Taiwan.
  • · The company contact is Gurmeet Dhaliwal (P: 408-232-9003, E: Gurmeet_Dhaliwal@diodes.com).
LiveOne, Inc. 8-K neutral materiality 5/10

28-07-2026

LiveOne, Inc. entered into a Shares Issuance Agreement with Music Story SAS on July 22, 2026, issuing 70,000 shares of common stock at $7.50 per share to settle outstanding and future fees under a Metadata license agreement. The license term was extended through February 24, 2028. The company will receive no cash proceeds from the issuance, and the shares are subject to trading volume restrictions.

  • · The shares are being issued under LiveOne's effective shelf Registration Statement on Form S-3 (File No. 333-284916), filed February 13, 2025.
  • · Music Story agreed not to sell shares exceeding 3.5% of the average daily trading volume for the preceding 20 consecutive trading days.
  • · Any remaining fees after the Extended Term (through February 24, 2028) will be paid in immediately available funds.
  • · The settlement of the share issuance is expected on or about July 29, 2026.
  • · LiveOne will not receive any cash proceeds from the offering of the shares.
Seritage Growth Properties 8-K neutral materiality 7/10

28-07-2026

Seritage Growth Properties entered into a $15.0M term loan and a $25.0M revolving credit facility with b1Bank on July 24, 2026, using proceeds plus cash to repay the $50.0M outstanding balance of its existing $1.60B loan from Berkshire Hathaway, which was terminated. The new facilities mature July 24, 2028, with one-year extension options, and bear interest at SOFR+2.75% (term) and money market+2.00% (revolver). The company also declared a $0.4375 per share preferred dividend payable October 15, 2026.

  • · The existing loan was originally $1.60B and was scheduled to mature on July 31, 2026.
  • · No prepayment penalties were triggered upon repayment of the existing loan.
  • · The new facilities are fully prepayable without penalty.
  • · Minimum liquidity covenants: $5.0M quarterly for both facilities; $10.0M as of Dec 31, 2027 for term loan only.
  • · Term loan requires a 1.15:1.00 debt service coverage ratio on collateralized properties.
  • · The preferred dividend of $0.4375 per share will be paid on October 15, 2026 to holders of record on September 30, 2026.
ASHLAND INC. 8-K positive materiality 7/10

28-07-2026

Ashland Inc. (NYSE: ASH) announced the appointment of two new independent directors, Peter Thomas and Allen Spizzo, and the formation of a Capital Allocation Advisory Committee as part of a cooperation agreement with stockholder Ancora Holdings Group. The Board will temporarily expand to 11 members before reducing to 10 at the 2027 Annual Meeting. The agreement includes customary standstill and voting commitments, reflecting a constructive engagement between the company and a significant shareholder.

  • · Peter Thomas is former chair, CEO and president of Ferro Corporation (sold to Prince International in 2022) and previously served on the board of Berry Global until its sale to Amcor in 2025.
  • · Allen Spizzo is former VP and CFO of Hercules Incorporated (sold to Ashland in 2008) and currently serves as investment advisor and trustee for the Dr. William Joyce family office.
  • · The Capital Allocation Advisory Committee will be chaired by current director Scott Tozier and includes directors Bertrand Loy, Susan L. Main, Peter Thomas, and Allen Spizzo; Guillermo Novo serves as non-voting member.
  • · Citi and Lazard are financial advisors to Ashland; Latham & Watkins is legal counsel; FGS Global is strategic communications advisor.
  • · Olshan Frome Wolosky LLP is legal counsel and Longacre Square Partners LLC is strategy advisor to Ancora.
Wendy's Co 8-K neutral materiality 3/10

28-07-2026

Wendy's Co disclosed a one-time restricted stock unit award of $500,000 to E.J. Wunsch, President, International, approved by the Compensation and Human Capital Committee on July 22, 2026. The award is intended to maintain continuity and recognize the performance and growth of the company's International business following the appointment of Robert D. Wright as President and CEO. The award vests in equal installments over two years, subject to continued employment.

  • · The award is granted under the company's 2020 Omnibus Award Plan.
  • · The grant date is effective August 11, 2026.
  • · Vesting occurs in substantially equal installments on each of the first two anniversaries of the grant date.
  • · The award is subject to Mr. Wunsch's continued employment on the applicable vesting dates.
Galaxy Digital Inc. 8-K positive materiality 9/10

28-07-2026

Galaxy Digital Inc. subsidiary Galaxy Helios Data Centers II LLC completed a $3.507B private offering of 9.875% Senior Secured Notes due 2031 to finance a 400 MW data center project in Texas for CoreWeave. The notes were issued at 99.5% of par and will amortize semi-annually starting at least ten months after project completion. Galaxy Digital Holdings LP provided an uncapped completion guarantee for the project.

  • · The notes are senior secured obligations of the issuer and will mature on August 1, 2031.
  • · Interest is payable semi-annually on February 1 and August 1, beginning February 1, 2027.
  • · The indenture includes covenants limiting additional indebtedness, dividends, investments, liens, asset sales, and affiliate transactions.
  • · The completion guarantee from Galaxy Digital Holdings LP is uncapped and covers any funding shortfall for the project phases required for CoreWeave's lease.
  • · The offering was conducted under Rule 144A and Regulation S, targeting qualified institutional buyers and non-U.S. persons.
Charlton Aria Acquisition Corp 8-K neutral materiality 5/10

28-07-2026

Charlton Aria Acquisition Corp appointed Paul Strickland as CFO and director, Kyoung Tak Kim as independent director and audit committee member, and Wang Jo Cha as independent director and compensation committee member, effective July 22, 2026. Jung Min Lee ceased as acting CFO but remains CEO. The appointments are part of the SPAC's preparation for a business combination, with deferred cash compensation for Strickland payable upon deal closure.

  • · Paul Strickland's compensation is deferred and payable in a lump sum upon consummation of a business combination, with no interest accrued.
  • · Kyoung Tak Kim is a licensed CPA in New York, New Jersey, Georgia, and South Korea, and a partner at LEK Partners LLC.
  • · Wang Jo Cha has four decades of experience in South Korean public finance and capital markets, including senior roles at KRX and KOSCOM.
  • · The company is a blank check company (SPAC) with a fiscal year end of December 31.
Global Asset Management Group, Inc. 8-K neutral materiality 3/10

28-07-2026

Global Asset Management Group, Inc. (KENS) announced the retirement of Director Daniel Snyder, effective July 24, 2026, and the appointment of David Marshall Nissman to the Board and Audit Committee. The company also appointed Daniel Bell and Darryl Barnes as Strategic Advisors to its Corporate Advisory Board to support growth, business planning, and shareholder communications. No financial metrics or performance data were disclosed in this filing.

  • · Daniel Snyder's resignation was for personal business reasons and not due to any dispute with the company.
  • · David Marshall Nissman previously served as the 19th United States Attorney for the District of the Virgin Islands.
  • · Daniel Bell has over two decades of experience in transfer agency operations and capital markets.
  • · Darryl Barnes served nine years in the Maryland General Assembly, including as Chief Deputy Majority Whip and Chairman of the Maryland Legislative Black Caucus.
HF Sinclair Corp 8-K neutral materiality 3/10

28-07-2026

HF Sinclair Corporation announced the retirement of Eric Nitcher, Executive Vice President and General Counsel, effective July 31, 2026. Mr. Nitcher will remain an employee through the end of 2026 to assist with the transition, and a successor will be named later. The retirement is not due to any disagreement with the company or its board.

  • · Eric Nitcher's retirement is effective July 31, 2026.
  • · He will remain an employee through the end of 2026 for an orderly transition.
  • · A successor has not yet been named.
VYNE Therapeutics Inc. 8-K mixed materiality 9/10

28-07-2026

Yarrow Bioscience completed its merger with VYNE Therapeutics, with the combined company now operating as Yarrow Bioscience and trading on Nasdaq under the ticker 'YARW'. The merger was supported by approximately $200 million in private financings led by RTW Investments, with participation from OrbiMed, Janus Henderson Investors, and others. Yarrow has initiated dosing in a Phase 2a/2b trial of YB-101 for Graves' disease, with Phase 2a data expected in 2H 2027, and the company expects its cash runway to fund operations into 2028. However, the merger resulted in a significant reverse stock split (1-for-50) for legacy VYNE shares, and the combined company's outstanding common stock is only approximately 2.8 million shares (or 33.6 million fully diluted), reflecting substantial dilution for prior VYNE shareholders.

  • · The merger closed on July 27, 2026, with shares trading on Nasdaq under 'YARW' starting July 28, 2026.
  • · VYNE distributed a special cash dividend of $17.3 million ($0.40242 per share) on July 23, 2026, prior to the merger.
  • · The reverse stock split of VYNE common stock at 1-for-50 was effected on July 24, 2026.
  • · The new CUSIP number for the combined company is 92941V407.
  • · YB-101 has received FDA Fast Track Designation.
  • · Phase 2a data expected in 2H 2027; Phase 2b expected to commence in 1H 2028.
  • · Data from the MAD portion of GenSci's Phase 1 TED trial also expected in 2H 2027.
  • · Cash runway expected to support operations into 2028.
Verisk Analytics, Inc. 8-K neutral materiality 4/10

28-07-2026

Verisk Analytics announced that EVP and CIO Nick Daffan will depart effective August 3, 2026, transitioning to a Strategic Advisor role through year-end. CTO Jeff Negrete will serve as interim CIO. Daffan's separation follows the company's Senior Executive Severance Benefits Plan.

  • · Nick Daffan had more than 20 years with the company.
  • · Daffan led the migration from mainframe to cloud and strengthened infrastructure for AI innovation.
  • · Jeff Negrete will serve as interim CIO in addition to his current CTO role.
  • · Separation terms are per Appendix A of the Verisk Senior Executive Severance Benefits Plan (disclosed April 5, 2022).
First Choice Healthcare Solutions, Inc. 8-K mixed materiality 8/10

28-07-2026

First Choice Healthcare Solutions, Inc. (FCHS) announced a definitive business combination agreement with Westin Acquisition Corp. (Nasdaq: WSTN) that values FCHS at a pro forma enterprise value of approximately $650 million. The combined company, which will rebrand as Wellgevity 360, is expected to trade on Nasdaq and close in Q4 2026. The deal aims to capitalize on the growing U.S. wellness economy, which the Global Wellness Institute values at $2.1 trillion growing at 7.9% annually, but the transaction remains subject to shareholder and regulatory approvals, and no specific financial performance metrics for FCHS are disclosed.

  • · The transaction is structured as a merger of Merger Sub into First Choice, with First Choice surviving as a wholly owned subsidiary of PubCo (the post-domestication Nevada corporation).
  • · Westin will domesticate from the Cayman Islands to Nevada prior to closing.
  • · The combined company is expected to trade on Nasdaq.
  • · The transaction has been approved by the boards of directors of both Westin and First Choice.
  • · Closing is subject to regulatory approvals, shareholder approvals of both companies, SEC effectiveness of a registration statement, and Nasdaq listing approval.
  • · No specific financial performance metrics (revenue, EBITDA, etc.) for First Choice were disclosed in this filing.
  • · The press release includes extensive forward-looking statements and risk factors.
Cboe Global Markets, Inc. 8-K neutral materiality 5/10

28-07-2026

Cboe Global Markets entered into a Third Amended and Restated Credit Agreement on July 24, 2026, replacing its existing $400 million revolving credit facility. The new agreement extends the maturity date and includes a syndicate of major banks as lenders and agents. The filing does not disclose the new facility size, interest rates, or financial covenant details, but the amendment and restatement of a material credit agreement is a routine financing event.

  • · The agreement is dated July 24, 2026, and was filed on July 28, 2026.
  • · The prior facility (Existing Credit Agreement) was dated February 25, 2022, with a $400M aggregate principal amount.
  • · The new agreement includes a swing line lender and allows for alternative currencies (Euro, Sterling).
  • · The facility is a revolving credit facility; the new aggregate commitment amount is not explicitly stated in the filing excerpt.
  • · Syndication agents include Agricultural Bank of China, Bank of China, Barclays, Goldman Sachs, JPMorgan, Morgan Stanley, and Toronto Dominion Bank.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Material Events SEC 8-K Filings

🇺🇸 More from United States

View all →